7 General discussion | 187 35. Xiao C, Fan T, Zheng Y, et al. H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy. J Immunother cancer. 2023;11(8). doi:10.1136/jitc-2022-005693 36. Gururajan M, Simmons A, Dasu T, et al. Early growth response genes regulate B cell development, proliferation, and immune response. J Immunol. 2008;181(7):4590-4602. doi:10.4049/jimmunol.181.7.4590 37. Xiao T, Li X, Felsenfeld G. The Myc-associated zinc finger protein (MAZ) works together with CTCF to control cohesin positioning and genome organization. Proc Natl Acad Sci U S A. 2021;118(7). doi:10.1073/ pnas.2023127118 38. Zheng C, Wu H, Jin S, Li D, Tan S, Zhu X. Roles of Myc-associated zinc finger protein in malignant tumors. Asia Pac J Clin Oncol. 2022;18(6):506-514. doi:10.1111/ajco.13748 39. McGinty RJ, Sunyaev SR. Revisiting mutagenesis at non-B DNA motifs in the human genome. Nat Struct Mol Biol. 2023;30(4):417424. doi:10.1038/s41594-023-00936-6 40. Guiblet WM, Cremona MA, Harris RS, et al. Non-B DNA: a major contributor to small- and large-scale variation in nucleotide substitution frequencies across the genome. Nucleic Acids Res. 2021;49(3):1497-1516. doi:10.1093/nar/gkaa1269 41. Wang G, Vasquez KM. Naturally occurring H-DNA-forming sequences are mutagenic in mammalian cells. Proc Natl Acad Sci U S A. 2004;101(37):13448-13453. doi:10.1073/ pnas.0405116101 42. Agard EA, Lewis SM. Postcleavage sequence specificity in V(D)J recombination. Mol Cell Biol. 2000;20(14):5032-5040. doi:10.1128/ MCB.20.14.5032-5040.2000 43. Lewis SM, Agard E, Suh S, Czyzyk L. Cryptic signals and the fidelity of V(D)J joining. Mol Cell Biol. 1997;17(6):3125-3136. doi:10.1128/ MCB.17.6.3125 44. Nilavar NM, Nishana M, Paranjape AM, et al. Znc2 module of RAG1 contributes towards structure-specific nuclease activity of RAGs. Biochem J. 2020;477(18):3567-3582. doi:10.1042/BCJ20200361 45. Iacobucci I, Mullighan CG. Genetic Basis of Acute Lymphoblastic Leukemia. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35(9):975-983. doi:10.1200/JCO.2016.70.7836 46. Thomson DW, Shahrin NH, Wang PPS, et al. Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia. Leukemia. 2020;34(8):2051-2063. doi:10.1038/s41375020-0751-y 47. Ochodnicka-Mackovicova K, Bahjat M, Maas C, et al. The DNA Damage Response Regulates RAG1/2 Expression in Pre-B Cells through ATM-FOXO1 Signaling. J Immunol. 2016;197(7):2918-2929. doi:10.4049/jimmunol.1501989 48. So S, Davis AJ, Chen DJ. Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites. J Cell Biol. 2009;187(7):977990. doi:10.1083/jcb.200906064 49. Minton K. How RAG2 cycles. Nat Rev Immunol. 2005;5(8):591. doi:10.1038/nri1673 50. Huang H, Regan KM, Wang F, et al. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci U S A. 2005;102(5):1649-1654. doi:10.1073/pnas.0406789102 51. Schlissel M, Constantinescu A, Morrow T, Baxter M, Peng A. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5’-phosphorylated, RAG-dependent, and cell cycle regulated. Genes Dev. 1993;7(12B):2520-2532. doi:10.1101/ gad.7.12b.2520 52. Lin WC, Desiderio S. Cell cycle regulation of V(D)J recombination-activating protein RAG-2. Proc Natl Acad Sci U S A. 1994;91(7):2733-2737. doi:10.1073/ pnas.91.7.2733 53. Lee J, Desiderio S. Cyclin A/CDK2 regulates V(D)J recombination by coordinating RAG-2 accumulation and DNA repair. Immunity. 1999;11(6):771-781. Accessed September 10, 2014. http://www.ncbi.nlm.nih.gov/ pubmed/10626899
RkJQdWJsaXNoZXIy MTk4NDMw